Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'20
Mar'19
Mar'18
Mar'17
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024
Compare Balance Sheet Results of Venmax Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.24
13.97
-8.73
-62.49%
Share Warrants & Outstandings
Total Reserve
-5.90
11.46
-17.36
-151.48%
Shareholder's Funds
4.41
25.43
-21.02
-82.66%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.05
0.05
100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
-0.05
0.05
100.00%
Current Liabilities
Trade Payables
0.63
0.00
0.63
0.00%
Other Current Liabilities
0.08
0.00
0.08
0.00%
Short Term Borrowings
0.05
0.16
-0.11
-68.75%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.76
0.17
0.59
347.06%
Total Liabilities
5.17
25.55
-20.38
-79.77%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.04
0.06
-0.02
-33.33%
Less: Accumulated Depreciation
0.00
0.06
-0.06
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
0.00
0.04
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
21.36
-21.36
-100.00%
Long Term Loans & Advances
0.00
1.28
-1.28
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.04
22.64
-22.60
-99.82%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.06
0.00
0.06
0.00%
Sundry Debtors
0.95
0.00
0.95
0.00%
Cash and Bank
2.48
2.86
-0.38
-13.29%
Other Current Assets
0.03
0.00
0.03
0.00%
Short Term Loans and Advances
1.61
0.05
1.56
3,120.00%
Total Current Assets
5.13
2.91
2.22
76.29%
Net Current Assets (Including Current Investments)
4.37
2.74
1.63
59.49%
Total Current Assets Excluding Current Investments
5.13
2.91
2.22
76.29%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
5.17
25.55
-20.38
-79.77%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.05
0.16
-0.11
-68.75%
Book Value per share (adjusted)
-1.26
18.20
-19.46
-106.92%
Annual - Borrowings
Borrowings 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Annual - Investments
No Investments in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 5.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024
